So you’re a pharmaceutical company, and you’ve just been accused of bribing doctors in a foreign country. What’s your next step? If you’re GlaxoSmithKline (GSK), the answer is eliminating much of the need for outside marketing altogether, as the company seeks to expand its team of in-house physicians by 10 to 20 percent over the next year.
GSK announced on April 17 that the company will be severing commercial ties with outside doctors. Instead, the company says, it will be expanding its in-house team already made up of 1,500 physicians.